Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
The Glutathione System: A New Drug Target in Neuroimmune Disorders — Gerwyn Morris (2014) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The Glutathione System: A New Drug Target in Neuroimmune Disorders
Shared by
Michael Maes
University of Electronic Science and Technology of China
The Glutathione System: A New Drug Target in Neuroimmune Disorders
Article
2014
en
Authors
+4 more
GM
Gerwyn Morris
GA
George Anderson
OD
Olivia Dean
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Recognizing the Leaky Gut as a Trans-diagnostic Target for Neuroimmune Disorders Using Clinical Chemistry and Molecular Immunology Assays
Denitsa Simeonova
,
Mariya Ivanovska
,
Marianna Murdjeva
,
André F. Carvalho
,
Michael Maes
Article
2015
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders
Gerwyn Morris
,
Ken Walder
,
Basant K. Puri
,
Michael Berk
,
Michael Maes
Article
2015
The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
Kurt Lucas
,
Gerwyn Morris
,
George Anderson
,
Michael Maes
Article
2020
Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
Seetal Dodd
,
André F. Carvalho
,
Basant K. Puri
,
Michael Maes
,
Chiara C. Bortolasci
,
Gerwyn Morris
,
Michael Berk
Article
2003
Spotlight on new anti-inflammatory drug targets in the immune system
Stephen G. Ward
,
Luke O'neill
Current Opinion in Immunology
Discussion(0)
No comments yet. Be the first to comment.